NCT00124228View on ClinicalTrials.gov

Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Cirrhosis
Interventions
DRUG

Human Albumin

albumin 1.5g/kg body weight the first day of inclusion plus 1g/kg/body weight the 3th day of inclusion.

Trial Locations (1)

08036

Hospital Clínic de Barcelona, Barcelona

All Listed Sponsors
collaborator

Fondo de Investigacion Sanitaria

OTHER

lead

Hospital Clinic of Barcelona

OTHER

NCT00124228 - Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis | Biotech Hunter | Biotech Hunter